- Home
- PVLA vs TPVG Comparison
PVLA vs TPVG Comparison
Compare PVLA & TPVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PVLA
- TPVG
- Stock Information
- Founded
- PVLA 2015
- TPVG 2013
- Country
- PVLA United States
- TPVG United States
- Employees
- PVLA N/A
- TPVG N/A
- Industry
- PVLA Biotechnology: Pharmaceutical Preparations
- TPVG Other Consumer Services
- Sector
- PVLA Health Care
- TPVG Consumer Discretionary
- Exchange
- PVLA Nasdaq
- TPVG Nasdaq
- Market Cap
- PVLA 280.4M
- TPVG 242.0M
- IPO Year
- PVLA N/A
- TPVG N/A
- Fundamental
- Price
- PVLA $22.77
- TPVG $6.23
- Analyst Decision
- PVLA Strong Buy
- TPVG Hold
- Analyst Count
- PVLA 7
- TPVG 6
- Target Price
- PVLA $44.43
- TPVG $6.55
- AVG Volume (30 Days)
- PVLA 82.1K
- TPVG 330.1K
- Earning Date
- PVLA 05-15-2025
- TPVG 05-07-2025
- Dividend Yield
- PVLA N/A
- TPVG 19.29%
- EPS Growth
- PVLA N/A
- TPVG N/A
- EPS
- PVLA N/A
- TPVG 0.93
- Revenue
- PVLA N/A
- TPVG $101,389,000.00
- Revenue This Year
- PVLA N/A
- TPVG N/A
- Revenue Next Year
- PVLA N/A
- TPVG $5.01
- P/E Ratio
- PVLA N/A
- TPVG $6.72
- Revenue Growth
- PVLA N/A
- TPVG N/A
- 52 Week Low
- PVLA $6.20
- TPVG $5.53
- 52 Week High
- PVLA $29.27
- TPVG $9.70
- Technical
- Relative Strength Index (RSI)
- PVLA N/A
- TPVG 49.15
- Support Level
- PVLA N/A
- TPVG $5.87
- Resistance Level
- PVLA N/A
- TPVG $6.18
- Average True Range (ATR)
- PVLA 0.00
- TPVG 0.18
- MACD
- PVLA 0.00
- TPVG 0.06
- Stochastic Oscillator
- PVLA 0.00
- TPVG 69.24
About PVLA Palvella Therapeutics Inc. Common Stock
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.
About TPVG TriplePoint Venture Growth BDC Corp.
TriplePoint Venture Growth BDC Corp is a closed-end, non-diversified management investment company. Its investment objective is to maximize its total return to stockholders in the form of current income and, to a lesser extent, capital appreciation. The fund focuses on companies operating in the fields of biofuels, business applications software, wireless communications equipment, e-commerce, clothing and accessories, conferencing equipment and services, personal goods, financial institutions and services, entertainment, mixed retailing, and healthcare services. Geographically, all the operations of the firm function through the region of the United states.